Using a single microcontroller port to drive a multi-digit LED display to help engineers with those last-minute design ...

IM1240 demonstrated improved safety in a toxicology study at doses up to 300-fold higher than a non-capped comparator ...

Most patients receiving a GLP-1 receptor agonist (RA) and a biologic continue co-therapy for over a year with few treatment-related adverse events.

On track to define optimal dosing interval and advance manufacturing scale up of REYOBIQ for pivotal trial readiness in late ...

Background Antifibrotic (AF) therapy has been shown to potentially reduce the risk of lung cancer (LC) in patients with ...

It’s just moving paper around. There’s no chance that one of the plaintiffs could continue to serve," Judge Judith Rogers ...

A large meta-analysis, published in Diabetology & Metabolic Syndrome, suggested that semaglutide improved several liver-related and metabolic outcomes in people with or at risk of developing MASH, ...

Explore the latest findings from the KATHERINE, PATINA, and HER2CLIMB-05 trials, highlighting advancements and challenges in breast cancer treatment.

Studies using brief and ultra-brief interventions more consistently resulted in positive r ...

A Type B meeting between the FDA and Plus Therapeutics offered clarity and direction for the next steps in development of ...

In today's healthcare environment, securing regulatory approval is only the beginning. The real challenge lies in ensuring ...